The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...

Limited (ASX:CSL) shares fell 5% after the global biotechnology company reported mixed results for the first half of fiscal year 2025, with its vaccine division Seqirus underperforming analysts' ...

Plasma Fractionation Market Share 2025 Plasma fractionation is a process of separating various components of plasma, which in turn is a com ...

Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

CSL consistency isn’t winning over investors, Ryan Stokes explains the new dump truck dance, and Macquarie’s return on equity ...

An estimated 12,000 children are born with thalassemia major, a severe form of the disease, in India each year, accounting ...

Australian biopharmaceutical company CSL reported a drop in vaccine sales due to falling immunization rates in the U.S., its largest market. The decline contributed to lower-than-expected profits, ...

CSL’s vaccine division is suffering as Americans turn away from flu vaccinations, with a “very severe” influenza season ...

Investing.com-- Australian biopharmaceutical giant CSL Ltd (ASX: CSL) reported a rise in half-year net profit, driven ...

Australian biopharmaceutical company CSL posted higher first-half profits as growth in its main blood-plasma business helped offset weaker flu vaccine sales, which were hit by "significantly" low ...

Throughout the month of February, Vitalant is holding a series of blood drives throughout the region, including one held ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...